Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19.
作者信息
Gong Wenping, Xie Jianping, Li Hao, Aspatwar Ashok
机构信息
Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8Medical Center of PLA General Hospital, Beijing, China.
Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Chongqing, China.
出版信息
Front Immunol. 2023 Feb 9;14:1147704. doi: 10.3389/fimmu.2023.1147704. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19.社论：结核病疫苗的研究进展及其对2019冠状病毒病的启示
Front Immunol. 2023 Feb 9;14:1147704. doi: 10.3389/fimmu.2023.1147704. eCollection 2023.
2
Hopes fizzle that a TB vaccine also fends off COVID.结核病疫苗也能抵御新冠病毒的希望破灭了。
Nature. 2023 May;617(7959):10. doi: 10.1038/d41586-023-01426-x.
3
Editorial: Reassessing Twenty Years of Vaccine Development against Tuberculosis.社论：重新评估结核病疫苗研发二十年
Front Immunol. 2018 Feb 7;9:180. doi: 10.3389/fimmu.2018.00180. eCollection 2018.
4
A review of vaccine research and development: tuberculosis.疫苗研发综述：结核病
Vaccine. 2005 Dec 30;23(50):5725-31. doi: 10.1016/j.vaccine.2005.07.045. Epub 2005 Aug 8.
5
Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?Covid-19 时代的结核病疫苗——我们还要等多久？
EBioMedicine. 2022 May;79:103993. doi: 10.1016/j.ebiom.2022.103993. Epub 2022 Apr 12.
6
The tuberculosis vaccine challenge.结核疫苗挑战。
Bull World Health Organ. 2023 May 1;101(5):303-304. doi: 10.2471/BLT.23.020523.
7
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.病毒载体结核病疫苗的研究进展及结核病疫苗研发的最新发现。
Front Immunol. 2022 Jun 23;13:895020. doi: 10.3389/fimmu.2022.895020. eCollection 2022.
8
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans.气溶胶传递而非肌肉注射腺病毒载体结核疫苗可诱导人体呼吸道黏膜免疫。
JCI Insight. 2022 Feb 8;7(3):e155655. doi: 10.1172/jci.insight.155655.
9
Synthetic protein conjugate vaccines provide protection against in mice.合成蛋白缀合物疫苗可在小鼠中提供针对 的保护。
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4). doi: 10.1073/pnas.2013730118.
10
Advances in protein subunit vaccines against tuberculosis.结核分枝杆菌蛋白亚单位疫苗的研究进展。
Front Immunol. 2023 Aug 15;14:1238586. doi: 10.3389/fimmu.2023.1238586. eCollection 2023.
引用本文的文献
1
A comprehensive approach to developing a multi-epitope vaccine against : from design to immunization evaluation.一种针对 的多表位疫苗的综合开发方法：从设计到免疫评估。
Front Immunol. 2023 Nov 2;14:1280299. doi: 10.3389/fimmu.2023.1280299. eCollection 2023.
2
Over 90% of Childhood BCG Vaccine-Induced Keloids in Japan Occur in Women.在日本，超过90%的儿童卡介苗接种后所致瘢痕疙瘩发生在女性身上。
Dermatol Ther (Heidelb). 2023 May;13(5):1137-1147. doi: 10.1007/s13555-023-00916-0. Epub 2023 Mar 23.
本文引用的文献
1
Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytes.新生儿卡介苗接种与循环单核细胞中长期的 DNA 甲基化特征有关。
Sci Adv. 2022 Aug 5;8(31):eabn4002. doi: 10.1126/sciadv.abn4002.
2
Viral vector vaccines.病毒载体疫苗。
Curr Opin Immunol. 2022 Aug;77:102210. doi: 10.1016/j.coi.2022.102210. Epub 2022 May 25.
3
BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.BCG 疫苗接种：对抗 COVID-19 和类似 COVID-19 的黑天鹅事件的潜在工具。
Int Immunopharmacol. 2022 Jul;108:108870. doi: 10.1016/j.intimp.2022.108870. Epub 2022 May 17.
4
BCG vaccination strategies against tuberculosis: updates and perspectives.BCG 疫苗接种策略防治结核病：更新与展望。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5284-5295. doi: 10.1080/21645515.2021.2007711.
5
Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.靶向分枝杆菌转运蛋白的人源抗体可介导对结核病的保护。
Nat Commun. 2021 Jan 27;12(1):602. doi: 10.1038/s41467-021-20930-0.
6
Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria.表达 LTAK63 佐剂的重组卡介苗诱导对分枝杆菌的早期和长期免疫应答增强。
Hum Vaccin Immunother. 2020 Mar 3;16(3):673-683. doi: 10.1080/21645515.2019.1669414. Epub 2019 Oct 31.
7
Final Analysis of a Trial of M72/AS01 Vaccine to Prevent Tuberculosis.M72/AS01 疫苗预防结核病的试验最终分析。
N Engl J Med. 2019 Dec 19;381(25):2429-2439. doi: 10.1056/NEJMoa1909953. Epub 2019 Oct 29.
8
Antibodies and tuberculosis: finally coming of age?抗体与结核病：终于迎来突破？
Nat Rev Immunol. 2018 Sep;18(9):591-596. doi: 10.1038/s41577-018-0028-0.
9
The current status, challenges, and future developments of new tuberculosis vaccines.新型结核疫苗的现状、挑战和未来发展。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1697-1716. doi: 10.1080/21645515.2018.1458806. Epub 2018 May 14.
10
Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis.重组卡介苗表达 LTAK63 佐剂诱导针对结核分枝杆菌的更好保护。
Sci Rep. 2017 May 18;7(1):2109. doi: 10.1038/s41598-017-02003-9.
Zotero 插件